Oswaldo Cruz Foundation

News and Video Search Results

News coverage

Global Hepatitis B Tests Market Forecasts to 2033: In-Depth Analysis of Segments, Regulatory Landscape, and Emerging Trends

GlobeNewswire 23 Jan 2024

Dublin, Jan. 23, 2024 (GLOBE NEWSWIRE) -- The "Hepatitis B Tests Market Size by Segments, Share, Regulatory, Reimbursement, and..

Hepatitis C Tests Market Size, Regulatory and Reimbursement Landscape, Procedures and Forecast to 2033
GlobeNewswire 28 Nov 2023
Global Plant-based Biologics and Expression Systems Market Report 2022-2035
GlobeNewswire 18 Apr 2022
Global Dengue Vaccines Disease Market Analysis Report 2021-2022: Dengvaxia's Uptake will Remain Minimal Before Pipeline Rivals Launch
GlobeNewswire 19 Apr 2021
Emergex Strengthens Senior Management Team
GlobeNewswire 23 Feb 2021

0 shares 1 views

You might like

Oswaldo Cruz Foundation media coverage

Brazil: Health Minister Says Population To Be Vaccinated By End Of Year

Brazil: Health Minister Says Population To Be Vaccinated By End Of Year

Eurasia Review 17 Feb 2021

By Marcelo Brandão

Brazil is set to immunize by the end of the year all of its population apt to receive the vaccine,..

COVID-19 Pandemic In Brazil Overwhelms Health Systems

COVID-19 Pandemic In Brazil Overwhelms Health Systems

Eurasia Review

16 Jan 2021

Global Meningococcal Vaccine Market By Brand, By Type, By Age Group, By Region, Industry Analysis and Forecast, 2020 - 2026

GlobeNewswire

10 Feb 2021

Emergex Vaccines signs Collaboration Agreement with Brazil’s Bio-Manguinhos/Fiocruz for the Development of a COVID-19 Vaccine
GlobeNewswire 05 Jan 2021
Brazil scrambles to approve virus vaccine as pressure mounts
SeattlePI.com 01 Jan 2021

Advertisement

More coverage

Brazil's Parana state agrees to produce Russian vaccine

Brazil's Parana state agrees to produce Russian vaccine

Al Jazeera STUDIO 23 Sep 2020

A Brazilian state has signed an agreement to produce Russia's COVID-19 vaccine, that some say was approved too quickly.

Outlook on the 2020 Dengue Vaccines Market - Approvals of TV003/TV005 and Domestic Vaccines Will Lead to Considerable Competition

GlobeNewswire

04 Dec 2020

Emergex Vaccines Raises US$11 million to Advance Pipeline of Synthetic T-Cell Vaccines for Infectious Diseases

GlobeNewswire

18 Nov 2020

Emergex Vaccines and George Mason University Identify T-Cell Epitopes Presented by SARS-Cov-2 Infected Cells

GlobeNewswire

15 Sep 2020